BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27231789)

  • 1. Got CER? Educating Pharmacists for Practice in the Future: New Tools for New Challenges.
    Perfetto EM; Anyanwu C; Pickering MK; Zaghab RW; Graff JS; Eichelberger B
    J Manag Care Spec Pharm; 2016 Jun; 22(6):609-16. PubMed ID: 27231789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making.
    Chen S; Graff J; Yun S; Beal B; Ta JT; Bansal A; Carlson JJ; Veenstra DL; Basu A; Devine B
    J Manag Care Spec Pharm; 2021 Jan; 27(1):95-104. PubMed ID: 33377442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability and Use of Comparative Effectiveness Research by P&T Committee Members and Support Staff: A 1-Year Follow-up.
    Augustine J; Warholak TL; Hines LE; Sun D; Brown M; Hurwitz J; Taylor AM; Brixner D; Cobaugh DJ; Schlaifer M; Malone DC
    J Manag Care Spec Pharm; 2016 Jun; 22(6):618-25. PubMed ID: 27231790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?
    Hurwitz JT; Brown M; Graff JS; Peters L; Malone DC
    J Manag Care Spec Pharm; 2017 Jun; 23(6):613-620. PubMed ID: 28530524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?
    Hurwitz JT; Brown M; Graff JS; Peters L; Malone DC
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1604-1611. PubMed ID: 33251991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does a One-Size-Fits-All Cost-Sharing Approach Incentivize Appropriate Medication Use? A Roundtable on the Fairness and Ethics Associated with Variable Cost Sharing.
    Graff JS; Shih C; Barker T; Dieguez G; Larson C; Sherman H; Dubois RW
    J Manag Care Spec Pharm; 2017 Jun; 23(6):621-627. PubMed ID: 28530519
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Curtiss FR; Fry RN; Avey SG
    J Manag Care Spec Pharm; 2020 Jul; 26(7):798-816. PubMed ID: 32584678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for pharmacoeconomic and outcomes research fellowship training programs: joint guidelines from the american college of clinical pharmacy and the international society of pharmacoeconomics and outcomes research.
    Kane-Gill S; Reddy P; Gupta SR; Bakst AW
    Pharmacotherapy; 2008 Dec; 28(12):1552. PubMed ID: 19025439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Pharmacy and Therapeutic (P&T) Committee member knowledge, attitudes and ability regarding the use of comparative effectiveness research (CER) in health care decision-making.
    Tang DH; Warholak TL; Hines LE; Hurwitz J; Brown M; Taylor AM; Brixner D; Malone DC
    Res Social Adm Pharm; 2014; 10(5):768-80. PubMed ID: 24480384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GRACE Checklist: A Validated Assessment Tool for High Quality Observational Studies of Comparative Effectiveness.
    Dreyer NA; Bryant A; Velentgas P
    J Manag Care Spec Pharm; 2016 Oct; 22(10):1107-13. PubMed ID: 27668559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Training, Responsibilities, and Practices of P&T Committee Members and Nonmember Contributors.
    Rodriguez R; Kelly BJ; Moody M
    J Manag Care Spec Pharm; 2017 Aug; 23(8):868-874. PubMed ID: 28737984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care decision makers' use of comparative effectiveness research: report from a series of focus groups.
    Villa L; Warholak TL; Hines LE; Taylor AM; Brown M; Hurwitz J; Brixner D; Malone DC
    J Manag Care Pharm; 2013; 19(9):745-54. PubMed ID: 24156643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a pharmacy teaching certificate program offered to practicing pharmacists.
    Cole JD; Ruble MJ; Wantuch G; Dell KA; Serag-Bolos E; Fox C; Perkins J
    Curr Pharm Teach Learn; 2019 Nov; 11(11):1152-1158. PubMed ID: 31783962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using an intervention mapping framework to develop an online mental health continuing education program for pharmacy staff.
    Wheeler A; Fowler J; Hattingh L
    J Contin Educ Health Prof; 2013; 33(4):258-66. PubMed ID: 24347104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing Patient Care Through Specialty Pharmacy Services in an Academic Health System.
    Bagwell A; Kelley T; Carver A; Lee JB; Newman B
    J Manag Care Spec Pharm; 2017 Aug; 23(8):815-820. PubMed ID: 28737983
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.